- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Tilray stock has been on a tear since its launch in 2018. But where did it all start? And what could be next for this licensed cannabis producer.
Tilray (NASDAQ:TLRY) is a licensed cannabis producer in Canada. The company is American-owned, but is based in Nanaimo, BC.
It sells cannabis and cannabis-related products domestically in Canada, as well as to countries in Europe, the South Pacific and Latin America.
After being a privately owned company for five years, Tilray was the first cannabis stock to launch on the NASDAQ on July 9, 2018. The stock offered to the public is Class 2 stock, which holds one vote per share; Class 1 stock on the other hand carries three votes per share.
Seventy-five million Class 1 shares are privately owned, making Tilray a “controlled company,” with the majority of its voting power privately controlled.
Tilray stock has skyrocketed from a starting price of US$17 after its IPO, and there are a number of factors that have caused the company’s exponential climb.
Those include a rumored deal with alcohol giant Diageo (LSE:DGE) — some believe Tilray is the frontrunner out of three candidates that have been earmarked as potential partners for the company. So far no other news has come out, but Tilray stock soared after this story broke out.
Another factor that has boosted Tilray stock is its Q2 2018 report, where it revealed a 95-percent increase in revenue year-over-year.
Some say Tilray stock will continue on its tear until October 17, 2018, the day cannabis is legalized in Canada. However, others believe the bubble will burst before that day comes, calling the company’s spike since its IPO unsustainable.
One cannabis analyst has suggested Tilray stock and other key players have been “hijacked by traders,” and has cautioned investors not to get caught up in the momentum. Time will tell for Tilray stock.
Don’t forget to follow us @INN_Cannabis for real-time updates!
Securities Disclosure: I, Amanda Kay, hold no direct investment interest in any company mentioned in this article.
Outlook Reports
Featured Cannabis Investing News Stocks
Browse Companies
MARKETS
COMMODITIES
Commodities | |||
---|---|---|---|
Gold | 2390.86 | +0.85 | |
Silver | 28.67 | +0.01 | |
Copper | 4.52 | +0.05 | |
Oil | 83.24 | +0.51 | |
Heating Oil | 2.55 | +0.01 | |
Natural Gas | 1.76 | 0.00 |
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.